Fred Alger Management’s Akoya BioSciences AKYA Stock Holding History

Fred Alger Management’s Portfolio AKYA Stock Details AKYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-262,212	Closed	-$1.94M	–	466
2023 Q2	$1.94M	Sell	262,212 -4,378	-2%	-$29.2K	0.01%	339
2023 Q1	$2.18M	Buy	266,590 +103	+0%	+$1.08K	0.01%	339
2022 Q4	$2.55M	Buy	266,487 +28	+0%	+$345	0.01%	318
2022 Q3	$3.13M	Hold	266,459	–	–	0.02%	295
2022 Q2	$3.42M	Sell	266,459 -5,358	-2%	-$55.5K	0.02%	294
2022 Q1	$2.99M	Sell	271,817 -1,537	-0.6%	-$17.8K	0.01%	316
2021 Q4	$4.18M	Sell	273,354 -9,424	-3%	-$123K	0.01%	314
2021 Q3	$3.95M	Buy	282,778 +4,452	+2%	+$74.4K	0.01%	303
2021 Q2	$5.38M	Buy	+278,326	New	+$5.75M	0.01%	289

Other funds holding AKYA

BWLSA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Fred Alger Management's AKYA Position: Q3 2023 in Review

Fred Alger Management sold out of Akoya BioSciences (AKYA) in Q3 2023, closing a stake of 262,212 shares — an estimated $1.94M sold.

Fred Alger Management first reported a position in AKYA in Q2 2021 and held it in 9 quarters. The position peaked at $5.38M in Q2 2021. 62 funds tracked by Wall St. Rank hold AKYA as of Q3 2023.

Fred Alger Management reported no remaining Akoya BioSciences position as of Q3 2023 after selling out during the quarter.
Fred Alger Management sold 262,212 Akoya BioSciences shares in Q3 2023, an estimated $1.94M.
Fred Alger Management first reported a position in Akoya BioSciences in Q2 2021 and held it in 9 quarters.
Fred Alger Management's Akoya BioSciences position peaked at $5.38M in Q2 2021.
62 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2023.

Based on Fred Alger Management's 13F filing for Q3 2023, filed 14 Nov 2023.